CABALETTA BIO, INC.
Last · NasdaqGS$1.79-0.14 (-7.25%)stale · yahoo · 57h ago
Market cap$303.49M169.5M sh
P/E · TTM-1.3fwd -1.5 · eps -1.51 · loss
Beta3.48vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.78$4.23
Volume4.8Msession
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-23
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.6 years
- Accumulated Deficit High — Accumulated deficit / equity 461%
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.31
Est. revenue
0
Earnings transcripts
Press & signals
- GlobeNewswire
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- GlobeNewswire
Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Documents
FormReporting forFiledFlags